The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

The president said he would build on the Medicare drug-price negotiation program begun under Joe Biden, but supports a change ...

Target has recalled 25,600 tubs of Good & Gather baby food because of elevated lead levels. The retailer on March 12 said two ...

CR highlights efforts to ban Red Dye No. 3 and other dangerous food additives and to stop automakers from sharing our driving ...

In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that “several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg ...

The agency and Novo Nordisk, which makes Ozempic, said Monday that they had learned about "several hundred units" of the drug ...

In recent weeks, Health and Human Services Secretary Robert F. Kennedy Jr. has said that "very, very strong studies" link ...

Donald Trump's healthcare revamp, emphasizing generics and biosimilars, could boost Indian drug makers, who already supply 40 ...

A company that makes baby food for Target is recalling more than 25,000 packages of a product because it may contain elevated ...

Pfizer has stopped the development of its weight loss pill after a patient experienced a liver injury that was potentially ...